Synthetic peptide corresponding to Human MFSD2A (C terminal).
(Peptide available as
Our Abpromise guarantee covers the use of ab105399 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 60 kDa.Can be blocked with MFSD2A peptide (ab199848).|
|ICC||Use a concentration of 20 µg/ml.|
|ELISA||Use at an assay dependent concentration.|
|IHC-P||Use a concentration of 5 µg/ml.|
ab105399 has not yet been referenced specifically in any publications.